Mesa Labs To Acquire Agena Bioscience For $300 Mln Cash - Quick Facts

Mesa Laboratories, Inc. (MLAB) announced Tuesday that it has entered into a definitive agreement to acquire Agena Bioscience, Inc. for a cash purchase price of $300 million, subject to customary purchase price adjustments.

Mesa expects to finance the all-cash transaction with a combination of cash on hand and proceeds from its credit facility.

The transaction is expected to be completed in Mesa's third fiscal quarter ending December 31, 2021, and is subject to customary conditions, including receipt of applicable regulatory approvals.

San Diego, California-based Agena is a leading molecular diagnostics tools company that develops, manufactures, and supplies highly sensitive, low-cost, high-throughput, genetic analysis solutions to clinical labs and development partners globally.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT